FERRONI, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 5.732
AS - Asia 3.531
EU - Europa 508
SA - Sud America 317
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 58
OC - Oceania 11
Totale 10.292
Nazione #
US - Stati Uniti d'America 4.992
TR - Turchia 1.776
CN - Cina 762
CA - Canada 708
SG - Singapore 667
BR - Brasile 256
IT - Italia 173
EU - Europa 132
VN - Vietnam 101
IN - India 74
IE - Irlanda 51
DE - Germania 45
GB - Regno Unito 45
FI - Finlandia 27
AR - Argentina 26
RU - Federazione Russa 26
ES - Italia 23
ID - Indonesia 23
BD - Bangladesh 21
MX - Messico 21
UA - Ucraina 20
FR - Francia 19
HK - Hong Kong 19
ZA - Sudafrica 19
JP - Giappone 16
PL - Polonia 16
SE - Svezia 14
EC - Ecuador 11
NL - Olanda 11
SA - Arabia Saudita 11
SC - Seychelles 9
AU - Australia 8
LT - Lituania 8
CL - Cile 7
IQ - Iraq 7
IR - Iran 7
KR - Corea 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
KE - Kenya 6
PK - Pakistan 6
CO - Colombia 5
MA - Marocco 5
EG - Egitto 4
PH - Filippine 4
RO - Romania 4
TN - Tunisia 4
JM - Giamaica 3
LB - Libano 3
PE - Perù 3
PY - Paraguay 3
SN - Senegal 3
TH - Thailandia 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
GR - Grecia 2
JO - Giordania 2
NZ - Nuova Zelanda 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
UZ - Uzbekistan 2
AD - Andorra 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NE - Niger 1
NO - Norvegia 1
NP - Nepal 1
NR - Nauru 1
PA - Panama 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.292
Città #
Kocaeli 1.570
San Mateo 1.183
Dallas 883
Toronto 674
Wilmington 331
Houston 301
Santa Clara 264
Singapore 238
Lawrence 223
Princeton 223
Beijing 201
Chandler 168
Ashburn 151
Fairfield 95
Seattle 88
Woodbridge 83
Shanghai 76
Los Angeles 71
Guangzhou 53
Ho Chi Minh City 45
Cambridge 41
Brooklyn 32
The Dalles 30
Rome 27
Shenzhen 27
Redwood City 23
New York 21
São Paulo 21
Council Bluffs 20
Helsinki 20
Columbus 19
Hanoi 18
Hong Kong 18
Dublin 17
Saint Petersburg 17
Chicago 16
Warsaw 14
Tokyo 13
Johannesburg 12
Milan 12
Redmond 12
Wuhan 12
Jiaxing 10
London 10
Montreal 10
Nanjing 10
Rio de Janeiro 10
Bandung 9
Kyiv 9
Mexico City 9
San Francisco 9
Stockholm 9
Wuxi 9
Xi'an 9
Atlanta 8
Ankara 7
Brasília 7
Denver 7
Munich 7
Phoenix 7
Turku 7
Boston 6
Chennai 6
Nairobi 6
Quanzhou 6
Seoul 6
Zhengzhou 6
Amsterdam 5
Belo Horizonte 5
Changsha 5
Curitiba 5
Hefei 5
Jakarta 5
Manchester 5
Taizhou 5
Wuhu 5
Aarhus 4
Bari 4
Buffalo 4
Da Nang 4
Frankfurt am Main 4
Guayaquil 4
Haiphong 4
Hyderabad 4
Las Vegas 4
Mumbai 4
Nantong 4
Pesaro 4
Pune 4
Qingdao 4
Queens 4
Quito 4
Riyadh 4
Rui'an 4
Santa Fe 4
Tehran 4
Washington 4
Xuzhou 4
Zibo 4
Austin 3
Totale 7.702
Nome #
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 117
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 117
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 109
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 95
Activation of blood coagulation in breast cancer - relationship to clinical outcome 92
Aging: an important risk factor in chemotherapy-associated vascular diseases 86
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 85
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 84
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 82
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 80
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 77
[New insights in the pathogenesis of prothrombotic state associated with hypercholesterolemia] 77
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 75
Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study 72
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 70
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 68
Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation 66
Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction 65
Anoxia-Reoxygenation Enhances Platelet Thromboxane A2 Production via Reactive Oxygen Species-Generated NOX2 Effect in Patients Undergoing Elective Percutaneous Coronary Intervention 64
A multiparametric index of platelet in vitro aggregation in cerebrovascular disease 61
Arterial hypertension and cardiovascular risk: need for a combined strategy of intervention 60
“Personal and sensitive data in the e-health-IoT universe” 58
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 58
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 57
Abnormal ventricular late potentials and in vivo platelet activation in Myotonic Dystrophy 57
Enhanced interleukin-1 beta in hypercholesterolemia - Effects of simvastatin and low-dose aspirin 57
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 56
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 56
Chronic obstructive pulmonary disease. A possible correlation between platelet aggregation tests and respiratory indexes. ECOB Group 56
Soluble P-selectin: A marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease 55
Role of interleukin-6 in the diagnosis of acute aortic dissection 55
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 55
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 55
ROLE OF TUMOR-CELL MEMBRANE GANGLIOSIDES IN PROMOTING PLATELET PROAGGREGATING ACTIVITY 55
In vitro interactions between blood platelets and human colorectal tumor cells 54
Endothelial dysfunction and oxidative stress in arterial hypertension 54
EVALUATION OF THE CLINICAL UTILITY OF PLATELET-AGGREGATION STUDIES IN THE LONG-TERM FOLLOW-UP OF PATIENTS WITH ATHEROSCLEROTIC VASCULAR-DISEASE 54
HEMOSTATIC BALANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 54
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 54
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 54
Higher oxidative stress in hepatitis C than hepatitis B virus cirrhotic patients 53
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 53
Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody 53
Is CEA serum measurement useful in monitoring breast cancer patients? 52
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 52
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 52
Interleukin-6 and haemostatic system in patients with chronic obstructive pulmonary disease 52
Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group 52
Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 52
Ideal Body Mass Index (BMI) difference between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 52
Impact of chemotherapy on activated protein C-dependent thrombin generation - association with venous thromboembolism occurrence 52
Machine learning approach to predict medication overuse in migraine patients 52
Artificial intelligence for cancer-associated thrombosis risk assessment 52
Platelet activation, inflammatory mediators and hypercholesterolemia 51
Platelet activation in type 2 diabetes mellitus 51
Ganglioside content of human platelets - Differences in resting and activated platelets 51
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 51
Non-Communicable Diseases: Gender Differences in Therapy 50
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 50
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 50
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 50
Effects of storage on in vitro platelet responses: Comparison of ACD and Na citrate anticoagulated samples 50
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 50
Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease 50
Serum Metalloproteinase-9 Levels in Patients with Coronary Heart Disease A Novel Marker of Inflammation 49
CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients 49
Changes of the lag phase of collagen-induced platelet aggregation in long-term aspirin therapy 49
EFFECTS ON PLATELET-FUNCTION BY HUMAN INTERFERON-BETA IN CARCINOMA PATIENTS 49
Biomarkers of platelet activation in acute coronary syndromes 49
Circulating Levels of Pro-Inflammatory Cytokines in Isolated Limb Perfusion 49
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 49
Assay for the detection of anti-idiotypic antibodies to monoclonal antibody B72.3 49
Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodies 49
Vascular endothelial growth factor levels in melanoma Relationship with coagulation and platelet activation markers 48
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 48
Tumor necrosis factor-alpha and myocardial function in patients with myotonic dystrophy type 1 48
Platelet activation and low-grade inflammation in hypertensives with or without microalbuminuria 48
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 48
Evaluation of the clinical impact of serum tumor markers in gastric cancer. A prospective longitudinal study 47
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 47
Correlation between platelet function and cytokine levels during hypothermic cardiopulmonary bypass 47
IS THE CD54 PROTEIN (ICAM-1) INVOLVED IN PLATELET-TUMOR CELL-INTERACTION 47
CLINICAL-EVALUATION OF THE NEW TUMOR-MARKER TAG-72 47
Low-density lipoprotein-lowering medication and platelet function 47
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 47
Breast Cancer Prognosis Using a Machine Learning Approach 47
Relation of Cytokine Production and Helicobacter Pylori Infection to Coronary Heart Disease 46
Evaluation of the Clinical Impact of Serum Tumor Markers in Colorectal Cancer A Prospective Longitudinal Study 46
CD40/CD40L system and vascular disease 46
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 46
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models 46
Prognostic value of vascular endothelial growth factor (VEGF) tumor tissue content in colorectal cancer - association with carcinoembryonic antigen (CEA) 45
Novel High-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in cancer patients 45
VEGF and VTE Risk in Cancer Patients-Letter 45
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 45
Identification of blood leukotrienes in classical migraine 45
Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer 45
Serum sE-Selectin Levels and Carcinoembryonic Antigen mRNA-Expressing Cells in Peripheral Blood as Prognostic Factors in Colorectal Cancer Patients 45
Association Between Birt Hogg Dube Syndrome and Cancer Predisposition 45
Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers 45
Totale 5.681
Categoria #
all - tutte 109.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.094 0 0 0 3 58 110 62 37 67 50 1.575 132
2021/20222.230 8 673 675 4 3 3 284 238 27 279 4 32
2022/2023841 490 18 18 54 33 11 2 35 31 65 84 0
2023/2024497 4 0 9 121 26 20 7 25 1 49 1 234
2024/20252.053 88 477 110 90 110 355 147 106 206 14 70 280
2025/20261.774 396 525 695 158 0 0 0 0 0 0 0 0
Totale 10.614